- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
RaySearch Laboratories AB ser. B (RAYb)
The RaySearch Labs B share price today is 194.20, view ST RAYb stock exchange data. Track the latest RaySearch Labs B share price with real-time updates on RAYb stock performance including market cap, day range, 52-week range and dividend yield. Access RAYb charts, earnings dates and analyst estimates to support your investment decisions.
Currency in SEK
194.20
+6.00(+3.19%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
189.20
201.00
52 wk Range
153.10
275.50
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
189.20201.00
52 wk Range
153.10275.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.10%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.10%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RAYb Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
297.50
Upside
+53.19%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 3 consecutive years
2_800x533_L_1412520354.jpg)
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 297.50
(+53.19% Upside)
Earnings
Latest Release
13-08-2026
EPS / Forecast
0.57 / 1.83
Revenue / Forecast
272M / 348.5M
Compare RAYb to Peers and Sector
Metrics to compare | RAYb | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRAYbPeersSector | |
|---|---|---|---|---|
P/E Ratio | 31.3x | 20.0x | −0.4x | |
PEG Ratio | 2.99 | 0.03 | 0.00 | |
Price/Book | 8.4x | 2.7x | 2.6x | |
Price / LTM Sales | 5.2x | 2.5x | 3.1x | |
Upside (Analyst Target) | 53.2% | 3.5% | 47.8% | |
Fair Value Upside | Unlock | 18.2% | 6.2% | Unlock |
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; Machine Learning; and Liver Ablation Solutions. The company was founded in 2000 and is headquartered in Stockholm, Sweden.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the RaySearch Labs B (RAYb) Share Price Today?
The RaySearch Labs B share price today is 194.20.
What is the current RaySearch Labs B (RAYb) share price and day range?
As of 15-08-2026, the RaySearch Labs B share price is 194.20, with a previous close of 188.20. The share price has ranged from 189.20 to 201.00 today, while the 52-week range spans from 153.10 to 275.50.
What Is the RaySearch Labs B Market Cap?
As of today, RaySearch Labs B market cap is 6.66B.
Does RaySearch Labs B Pay Dividends? What's The Current Dividend Yield?
The RaySearch Labs B dividend yield is 2.1%.
What Is the RaySearch Labs B (RAYb) Share Price Target?
The average 12-month share price target for RaySearch Labs B is 297.50, with a high estimate of 345 and a low estimate of 250. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +53.19% Upside potential.
What Is RaySearch Labs B's Earnings Per Share (TTM)?
The RaySearch Labs B EPS (TTM) is 6.53.
When Is the Next RaySearch Labs B Earnings Date?
RaySearch Labs B will release its next earnings report on 03-11-2026.
From a Technical Analysis Perspective, Is RAYb a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
What Stock Exchange Does RaySearch Labs B Trade On?
RaySearch Labs B is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for RaySearch Labs B?
The stock symbol for RaySearch Labs B is "RAYb."
How Many Times Has RaySearch Labs B Stock Split?
RaySearch Labs B has split 2 times.
How Many Employees Does RaySearch Labs B Have?
RaySearch Labs B has 465 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.